Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes

AIMS/INTRODUCTION: Type 2 diabetes mellitus is a progressive disease that frequently requires patients to use more than one oral antihyperglycemic agent to achieve adequate glycemic control. The present multicenter, randomized study assessed the efficacy and safety of the addition of sitagliptin to...

Descripción completa

Detalles Bibliográficos
Autores principales: Tajima, Naoko, Kadowaki, Takashi, Okamoto, Taro, Sato, Asako, Okuyama, Kotoba, Minamide, Toshiomi, Arjona Ferreira, Juan Camilo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley-Blackwell 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020255/
https://www.ncbi.nlm.nih.gov/pubmed/24843714
http://dx.doi.org/10.1111/jdi.12116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020255/
https://www.ncbi.nlm.nih.gov/pubmed/24843714
http://dx.doi.org/10.1111/jdi.12116

Ejemplares similares